In man Neptazane reaches its maximum concentration in the blood within 3 to 6 hrs after a dose of 5 to 7 5 mg./kg. Renal clearance is 4 to 8 times slower than that of Diamox and 24-hr recoveries from urine were only [15] [16] [17] [18] [19] per cent. of the dose. It has been estimated that 43-58 per cent. of a small dose is metabolized.
In man the 24-hr urinary loss of sodium and potassium is said to be greater than after a comparable single dose of Diamox (Lederle). The urinary citrate excretion is, however, not depressed.
It is still an interesting matter for discussion and one of great physiological interest whether these carbonic anhydrase inhibitors such as Diamox or Neptazane lower the intra-ocular pressure by diminishing the formation of aqueous humour (Becker and Constant, 1955; Langham and Lee, 1957; Langham, 1958) as the result of suppressing the formation of bicarbonate ions (Becker, 1956) , or whether their effect on the eye is secondary to the osmotic changes in the blood induced by diuresis and by the loss of cations particularly of sodium. Langham (1958) has recently compared the specificity and comparative activity of the two compounds with regard to their action on intra-ocular pressure.
In rabbits and cats, Neptazane was two to three times more active than Diamox in lowering the intra-ocular pressure, and it also caused an immediate and concurrent decrease in the rate of formation of aqueous humour.
Neptazane was also effective in man, and Langham found that single doses of 250 and 125 mg. depressed the intra-ocular pressure for a minimum of 20 hrs and 12 hrs respectively. His records in human subjects were, however, obscured by the concurrent use of miotics.
By comparison with allied chemical compounds, Langham also demonstrated that the specificity of the action of Neptazane and of Diamox upon the eye depended on the presence of a free sulphonamide group-which is essential also for carbonic anhydrase inhibition.
Having full regard to the observations which have already been carried out upon the action of Neptazane, it appeared highly desirable to explore the relationship between its intra-ocular and systemic effects, since this proved to be of considerable significance in the case of Diamox and led to its wiser therapeutic use.
As in the case of Diamox (Campbell, Tonks, and Jones, 1956; Campbell, Jones, Renner, and Tonks, 1957; Campbell, Renner, and Tonks, 1958) , the effect of single and repeated doses of Neptazane was investigated in glaucomatous patients without the concurrent use of miotics.
As far as its systemic effects were concerned we had in mind two particular problems:
(a) Whether it induces a state of acidosis, and how long this persists;
(b) The possible danger that the body may be drained of electrolytes by continuous use of the drug.
The opportunity was taken to compare the action of Neptazane with that of Diamox under the same experimental conditions.
Experimental Procedure
In order to get a clear assessment of the effect of any drug which lowers intraocular pressure, we have found by experience that the subject should be at rest in bed, or sitting quietly in a chair, and that no miotics should be used. The diurnal variation in pressure should be recorded for a preliminary period of 2 to 3 days, since individual subjects often show a considerable rise and fall which tends to lessen with rest. Tonometric readings taken at random as an out-patient are of little value-since the peak of the intra-ocular pressure is often never found. Therapeutically it is important to know in each individual the time of day at which this peak occurs, so that the drug can be administered at the optimum time, i.e. just before the peak.
It is desirable to take additional precautions during such investigations, such as keeping the patient on a known diet, low in sodium, and in a state of steady hydration throughout the day, knowing for instance that the imbibition of a large amount of fluid can affect the intra-ocular pressure.
Such precautions were observed in these investigations and the same routine was adopted as already described in our previous work on Diamox.
Five volunteer subjects affected with glaucoma were tested each for a period of from 5 to 10 days under strictly comparable conditions. In each of these patients the angles of the anterior chamber were "open" or of medium size.
Results
Effects of a Single Dose of Neptazane (a) Ocular Response.-It was soon evident from preliminary tests that, although a dose of 125 mg. Neptazane can depress the intra-ocular pressure for as long as 18 hrs, a single dose of 250 mg. is much more effective in the glaucomatous eye.
The response varied in different individuals (see Fig. 1 , overleaf, in which each curve is the average response for 2 eyes in each individual). A dose of 250 mg. Neptazane caused an immediate average fall of 15 mm.Hg during the first 4 hrs, and the effect lasted for as long as 43 hrs. There was an interim peak in each case at about 19 hrs-following the pattern of the normal diurnal excursion. Sodium and chloride showed an immediate and noticeable fall and remained at a low level for 48 hrs and 24 hrs respectively. Sulphates were similarly affected for 48 hrs. The bicarbonate was unaffected for the first 6 hrs, i.e. during the period of rapid fall of intra-ocular pressure, but then declined for more than 48 hrs. Potassium, magnesium, and proteins fell during the first 6 hrs. Calcium was relatively unaffected and the phosphates rose temporarily. Urinary excretion showed an immediate diuresis and a rise in output of sodium and of potassium which coincided with the period of fall in intraocularpressure (Fig. 2) . Theurinewas markedlyalkaline withapH above7-0. In comparing the 24-hr output after Neptazane with that of the previous day, there was a real increase in volume, and in sodium and potassium excretion, but the chloride output was unchanged or showed a slight decline.
CHANGES IN ELECTROLYTES OF THE BLOOD AFTER
In the period of 24 to 48 hrs after Neptazane the urine was acid and its volume returned to its predosage level. The output of sodium, potassium, and chloride fell to below the predosage level.
(c) Comparison with Effect of Diamox.-The effect of 250 mg. Neptazane, compared with that of 250 mg. Diamox, may be summarized as follows:
(i) The intra-ocular pressure fell more slowly during the first 3 hrs, but reached the same level after 4 hrs as that caused by Diamox (Fig. 3) (ii) In the blood the changes in sodium, potassium, proteins, and bicarbonate followed much the same pattern, the fall in the bicarbonate being longer delayed after Neptazane than after Diamox. There was a difference in the behaviour of the chlorides in the first 6 hrs; they tended to rise after Diamox and to fall after Neptazane (Fig. 4, opposite) . In the 24-hr output the diuresis caused by Neptazane was much less (an increase of 33 per cent. as compared with 75 per cent. after Diamox). The output of sodium and potassium was much larger (an increase of 90 and 80 per cent. as compared with 60 and 58 per cent. respectively). The output of chloride actually declined by 17 per cent. whereas it increased by 110 per cent. after Diamox. Although the bicarbonate output was not measured quantitatively it was decidedly less after Neptazane than after Diamox.
Effects of Repeated Doses of Neptazane
In order to discover the optimum size and frequency of the dose applicable for continuous therapy, Neptazane was given over a period of several days in three individual subjects, as follows ( Fig. 6 (b) Systemic Response.-Blood analyses were restricted to the more significant constituents-sodium, potassium, chloride, and proteins. During each period of fall in intra-ocular pressure there was a corresponding fall in sodium, chloride, and proteins (Fig. 7) There was an overall decrease in the level of chloride, proteins, and potassium during the 4 days of the test. The daily fluctuations in sodium became larger, but the level was well maintained (Fig. 7) .
On each of the first 2 days the urinary changes were substantially the same as after a single dose, but thereafter the response declined and the urinary volume and output of sodium and potassium reverted to a predosage level. Chloride excretion declined steadily from the first day, and the urine remained alkaline for a shorter time after each dose (Fig. 8) Neptazane given 12-hrly augmented the total daily output of electrolytes, especially of potassium. This was regarded as an undesirable feature, since it gave no greater control of the intra-ocular pressure. (i) The most striking difference was that, whereas Neptazane could be relied upon to maintain a continuous control of intra-ocular pressure and in some instances to produce an increasing effect on each successive day, in the majority of cases Diamox had a diminishing effect (Fig. 9) , unless (as was found by previous experience) potassium bicarbonate was given as an adjuvant (Campbell, Jones, Renner, and Tonks, 1957 (ii) The electrolytes in the blood varied in much the same way with the difference that no hyperchloraemia, such as occurs after Diamox, was observed.
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-(iii) Diuresis tended to decrease after the first day, as did the output of sodium and potassium after either Neptazane or Diamox. The output of chloride declined markedly after continuous administration of Neptazane (Fig. 10) 
Summary (1) Effect of Single Dose
(a) The effect of a single dose of 250 mg. Neptazane on intra-ocular pressure is materially the same as that of 250 mg. Diamox, but the action is slower and more prolonged.
(b) During the period of fall in intra-ocular pressure there is an accompanying fall in sodium, potassium, chloride and proteins of the blood, whereas the fall in bicarbonate does not occur for 6 to 7 hrs.
(c) A moderate diuresis occurs during the same period, and is accompanied by a marked rise in the excretion of sodium and potassium, and a decline in the excretion of chloride.
(2) Effect of Repeated Doses (a) The optimum effect on reduction of intra-ocular pressure was obtained by the administration of 125 mg. Neptazane at intervals of 24 hrs. There was an immediate response to each successive dose and an overall decline in intra-ocular pressure which was maintained so long as the drug was continued.
(b) Each dose gave rise to an immediate fall in sodium, potassium, chloride, and proteins in the blood, and to an overall decline in all but sodium, the level of which was well maintained.
(c) On each of the first 2 days the urinary changes were the same as after a single dose. Thereafter the response declined and the urinary volume and output of sodium and potassium reverted to a predosage level. Chloride excretion declined from the first day.
(d) Increased frequency of dosage, e.g. 125 mg. administered 12-hrly, gave no better control of intra-ocular pressure and it augmented the output of potassium.
(3) Therapeutic Indications for the Use of Neptazane
There is a close similarity in the action of Neptazane and Diamox on the intra-ocular pressure and in their systemic effects.
The evidence presented in this paper confirms the clinical findings of Becker (1957) , and it is hoped that it will provide reliable criteria for the therapeutic use of Neptazane.
(i) Owing to its slowness of action, Neptazane is less suitable than Diamox for the rapid reduction of intra-ocular pressure in cases of acute glaucoma.
(ii) A dose of 250 mg. Neptazane is equivalent to 250 mg. Diamox where more prolonged action is desired, or in cases which do not respond to Diamox.
(iii) Neptazane is particularly suitable for long-term therapy as, in contrast to Diamox, it continues to be effective, whereas the effect of Diamox declines unless it is potentiated by miotics or by the simultaneous administration of potassium bicarbonate. A dose of 125 mg. Neptazane, administered daily, appears to be adequate, but this might be increased to 250 mg. given at intervals of 24 or 48 hrs.
(iv) The administration of the drug more than once in 24 hrs is undesirable, since it increases the bodily loss of potassium, and gives no greater reduction of intra-ocular pressure.
In conclusion, the most noticeable physiological feature of the action of Neptazane is the close correlation between the fall in the intra-ocular pressure with the fall in the electrolytes and their increased excretion. The osmotic changes which it causes in the plasma may in fact be greater than those which follow the use of Diamox, since the induced diuresis is comparatively less and the excretion of sodium and potassium is higher.
It would be interesting to investigate more precisely how closely the intra-ocular pressure in man responds to osmotic changes in the blood, when the latter occur naturally or are induced therapeutically.
Some very stimulating work on this particular relationship as it occurs in rabbits has recently been published by Cole (1959) .
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